Zortix
Ask Zortix…⌘KSign in

What finance podcasts are saying aboutCVS HealthCVSNYSE

According to Zortix's podcast index, CVS Health (CVS) was discussed on 2 finance podcasts across 2 episodes in the 30 days to 27 Aug 2026, generating 2 attributed ideas — most coverage from Motley Fool Money and Yet Another Value Podcast.

Mentions · 7d
1
Mentions · 30d
2
Mentions · 90d
2
Episodes · 30d
2
Shows · 30d
2
Vs prior week
+1
Discussion depth
Substantive discussion
As of 25 Aug 2026
Ask Zortix about CVS

Key facts

Exchange
NYSE
Sector
Healthcare
Industry
Retail-Drug Stores and Proprietary Stores
Headquarters
Woonsocket, RI
Incorporated in
Delaware
Fiscal year ends
31 December
Formerly
Cvs Caremark Corp

Listing and registration facts from public registries · SEC EDGAR filings for CVS. Not a rating, forecast or recommendation.

Top shows by coverage · 30 days

ShowIdeasEpisodes
Motley Fool Money11
Yet Another Value Podcast11

Latest ideas · headlines, attributed

25 AUG2D AGOMOTLEY FOOL MONEY
Substantive discussionOpen in Zortix →Thesis and listen link in the app
7 AUG3W AGOYET ANOTHER VALUE PODCAST
Notable commentOpen in Zortix →Thesis and listen link in the app
1 MAY1 MAYTHE BEST EVER CRE SHOW · JOHN CHANG
Substantive discussionOpen in Zortix →Thesis and listen link in the app

Definitions

Mention
One attributed idea naming this ticker, extracted from a podcast episode and dated by the episode’s air date. How we count →
Attributed idea
A specific argument a named speaker made on a named show — never an aggregate opinion, never Zortix’s view. What qualifies →
Discussion depth
How thoroughly an idea was argued on the episode, from a brief mention to a core thesis — a description of the conversation, not a rating of the stock. The bands →
Stance mix
Counts of attributed ideas by the side each argued on this name — bullish, balanced, or bearish as the speaker put it. A tally of the conversation’s sides, never a combined score, a rating, or Zortix’s view.
MENTIONS, DEPTH, STANCE MIX & COVERAGE REFLECT PODCAST DISCUSSION · NOT A RATING, FORECAST, OR RECOMMENDATION